Payment default: three consecutive missed instalments
Bloxers: side-effect reports that cannot be revised →Bloxers Health Data Inc. has not made a scheduled payment since June 2026. The clinical pilot the loan was underwritten against was refused at ethics review in March on a data-controller objection. The borrower has stated it will not resume payments and has proposed a debt-for-equity conversion. An asset sale to a third party is the alternative.
Evidence
Anyone in the case may file an exhibit. Nobody may remove one.
Ethics review determination
Texas hospital network review board, refusal on data-controller grounds.
Filed by Anouk Vermeer · Aug 13, 2026
Counsel opinion on the IP charge
Charge registered and enforceable; no competing security.
Filed by Marguerite Okonjo · Aug 27, 2026
Indicative acquirer correspondence
180–240 BSV range, non-binding, two conversations.
Filed by Abhi Sridharan · Aug 14, 2026
Borrower conversion proposal
Debt-for-equity at a founder-proposed valuation.
Filed by Anouk Vermeer · Aug 15, 2026
Timeline
Borrower notified lenders it would miss June and subsequent instalments
Anouk Vermeer · Jun 30, 2026
Case opened following third missed instalment
Marguerite Okonjo · Aug 12, 2026
Indicative recovery range circulated
Abhi Sridharan · Aug 14, 2026
Counsel opinion filed; recommendation issued
Marguerite Okonjo · Aug 27, 2026
Lender vote opens
System · Sep 5, 2026
Case room
The case room is open to lenders holding a position in this loan, to the borrower, and to the arbitration team. The file above, the evidence, the timeline and the outcome, is public and stays public.
How arbitration works